Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/17558 |
Resumo: | Chronic Obstructive Pulmonary Disease (COPD) is a lung disease, often associated with smoking. COPD patients have persistent, including urinary incontinence. Therefore, a research has the general objective of knowing the physiological mechanism of urinary incontinence associated with the pharmacological treatment of COPD. As a methodological process, this study is an integrative review that included randomized clinical trials, quasi-experimental intervention studies, cohort and case-control. The selection of studies was carried out in the databases PubMed, SciELO, Science Direct and BVS (Virtual Health Library), published between 2010 and July 2020, in Portuguese and English. Pharmacological classes SABA, LABA, SAMA, LAMA, ICS and iPDE4 were considered to investigate adverse effects and check for the presence of urinary symptoms caused by these drugs. In the results and discussion, 113 articles were identified with the investigated descriptors. After the article selection process, 14 studies resulted: PubMED (13); and Science Direct (1). The pharmacological class related to urinary incontinence identified in this study was that of anticholinergics / antimuscarinics. From this perspective, it can be considered that Urinary Incontinence has a low relationship with the adverse effects of drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD). However, as urinary incontinence is not considered a life-threatening problem, it is possible that it has not been included among the adverse events to be explored. |
id |
UNIFEI_c57e2256a9c2927dc4c4b7068704dc04 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/17558 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative reviewIncontinencia urinaria asociada con el tratamiento farmacológico de la Enfermedad Pulmonar Obstructiva Crónica: Una revisión integrativaIncontinência urinária associada ao tratamento farmacológico da Doença Pulmonar Obstrutiva Crônica: Uma revisão integrativaIncontinência UrináriaTratamento FarmacológicoDoença pulmonar obstrutiva crônica. Incontinencia UrinariaTratamiento FarmacológicoEnfermedad pulmonar obstructiva crónica.Urinary IncontinencePharmacological treatmentChronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease (COPD) is a lung disease, often associated with smoking. COPD patients have persistent, including urinary incontinence. Therefore, a research has the general objective of knowing the physiological mechanism of urinary incontinence associated with the pharmacological treatment of COPD. As a methodological process, this study is an integrative review that included randomized clinical trials, quasi-experimental intervention studies, cohort and case-control. The selection of studies was carried out in the databases PubMed, SciELO, Science Direct and BVS (Virtual Health Library), published between 2010 and July 2020, in Portuguese and English. Pharmacological classes SABA, LABA, SAMA, LAMA, ICS and iPDE4 were considered to investigate adverse effects and check for the presence of urinary symptoms caused by these drugs. In the results and discussion, 113 articles were identified with the investigated descriptors. After the article selection process, 14 studies resulted: PubMED (13); and Science Direct (1). The pharmacological class related to urinary incontinence identified in this study was that of anticholinergics / antimuscarinics. From this perspective, it can be considered that Urinary Incontinence has a low relationship with the adverse effects of drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD). However, as urinary incontinence is not considered a life-threatening problem, it is possible that it has not been included among the adverse events to be explored.La enfermedad pulmonar obstructiva crónica (EPOC) es una enfermedad pulmonar, a menudo asociada con el tabaquismo. Los pacientes con EPOC tienen incontinencia urinaria persistente, incluida. Por tanto, una investigación tiene como objetivo general conocer el mecanismo fisiológico de la incontinencia urinaria asociado al tratamiento farmacológico de la EPOC. Como proceso metodológico, este estudio es una revisión integradora que incluyó ensayos clínicos aleatorizados, estudios de intervención cuasiexperimentales, de cohortes y de casos y controles. La selección de estudios se realizó en las bases de datos PubMed, SciELO, Science Direct y BVS (Virtual Health Library), publicadas entre 2010 y julio de 2020, en portugués e inglés. Se consideraron las clases farmacológicas SABA, LABA, SAMA, LAMA, ICS e iPDE4 para la investigación de efectos adversos y verificación de la presencia de síntomas urinarios causados por estos fármacos. En los resultados y discusión se identificaron 113 artículos con los descriptores investigados. Tras el proceso de selección de artículos, resultaron 14 estudios: PubMED (13); y Science Direct (1). La clase farmacológica relacionada con la incontinencia urinaria identificada en este estudio fue la de anticolinérgicos / antimuscarínicos. Desde esta perspectiva, se puede considerar que la Incontinencia Urinaria tiene una baja relación con los efectos adversos de los fármacos para el tratamiento de la Enfermedad Pulmonar Obstructiva Crónica (EPOC). Sin embargo, como la incontinencia urinaria no se considera un problema potencialmente mortal, es posible que no se haya incluido entre los eventos adversos que se explorarán.A Doença Pulmonar Obstrutiva Crônica (DPOC), é uma doença pulmonar, frequentemente associada ao tabagismo. Pacientes com DPOC apresentam sintomas persistentes, incluindo a incontinência urinária. Diante disso, a pesquisa tem como objetivo geral de conhecer o mecanismo fisiológico da incontinência urinária associada ao tratamento farmacológico da DPOC. Como processo metodológico, este estudo trata-se de uma revisão integrativa onde foram incluídos ensaios clínicos randomizados, estudos de intervenção quase-experimentais, coorte e caso-controle. A seleção dos estudos foi realizada nas bases de dados PubMed, SciELO, Science Direct e BVS (Biblioteca Virtual em Saúde), publicados entre 2010 a julho de 2020, nos idiomas português e inglês. Foram considerados as classes farmacológicas SABA, LABA, SAMA, LAMA, ICS e iPDE4 para investigação dos efeitos adversos e verificação da presença de sintomas urinários causados por esses fármacos. Nos resultados e discussão foram identificados 113 artigos com os descritores investigados. Após o processo de seleção dos artigos, resultaram em 14 estudos: PubMED (13); e Science Direct (1). A classe farmacológica relacionada com a incontinência urinária identificada neste estudo foi a dos anticolinérgicos/antimuscarínicos. Nessa perspectiva, pode-se considerar que a Incontinência Urinária tem baixa relação com os efeitos adversos dos medicamentos para o tratamento da Doença Pulmonar Obstrutiva Crônica (DPOC). No entanto, como a incontinência urinária não é considerada um problema com risco de vida, é possível que não tenha sido incluída entre os eventos adversos a serem explorados.Research, Society and Development2021-07-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1755810.33448/rsd-v10i9.17558Research, Society and Development; Vol. 10 No. 9; e3810917558Research, Society and Development; Vol. 10 Núm. 9; e3810917558Research, Society and Development; v. 10 n. 9; e38109175582525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/17558/15873Copyright (c) 2021 Phydel Palmeira Carvalho; Roberto Bandeira Tosta Maciel; Gabriel Couto Rocha; Murilo de Jesus Porto; Juliana Santana Montalvão Galliza; Karla Ramos Melo Oliveira; Aquiles Assunção Camelier; Rosa Malena Fagundes Xavier; Fernanda Warken Rosa Camelierhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCarvalho, Phydel PalmeiraMaciel, Roberto Bandeira TostaRocha, Gabriel CoutoPorto, Murilo de JesusGalliza, Juliana Santana MontalvãoOliveira, Karla Ramos MeloCamelier, Aquiles AssunçãoXavier, Rosa Malena FagundesCamelier, Fernanda Warken Rosa2021-09-12T14:28:06Zoai:ojs.pkp.sfu.ca:article/17558Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:52.633784Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review Incontinencia urinaria asociada con el tratamiento farmacológico de la Enfermedad Pulmonar Obstructiva Crónica: Una revisión integrativa Incontinência urinária associada ao tratamento farmacológico da Doença Pulmonar Obstrutiva Crônica: Uma revisão integrativa |
title |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
spellingShingle |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review Carvalho, Phydel Palmeira Incontinência Urinária Tratamento Farmacológico Doença pulmonar obstrutiva crônica. Incontinencia Urinaria Tratamiento Farmacológico Enfermedad pulmonar obstructiva crónica. Urinary Incontinence Pharmacological treatment Chronic obstructive pulmonary disease. |
title_short |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
title_full |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
title_fullStr |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
title_full_unstemmed |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
title_sort |
Urinary incontinence associated with pharmacological treatment of Chronic Obstructive Lung Disease: An integrative review |
author |
Carvalho, Phydel Palmeira |
author_facet |
Carvalho, Phydel Palmeira Maciel, Roberto Bandeira Tosta Rocha, Gabriel Couto Porto, Murilo de Jesus Galliza, Juliana Santana Montalvão Oliveira, Karla Ramos Melo Camelier, Aquiles Assunção Xavier, Rosa Malena Fagundes Camelier, Fernanda Warken Rosa |
author_role |
author |
author2 |
Maciel, Roberto Bandeira Tosta Rocha, Gabriel Couto Porto, Murilo de Jesus Galliza, Juliana Santana Montalvão Oliveira, Karla Ramos Melo Camelier, Aquiles Assunção Xavier, Rosa Malena Fagundes Camelier, Fernanda Warken Rosa |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Carvalho, Phydel Palmeira Maciel, Roberto Bandeira Tosta Rocha, Gabriel Couto Porto, Murilo de Jesus Galliza, Juliana Santana Montalvão Oliveira, Karla Ramos Melo Camelier, Aquiles Assunção Xavier, Rosa Malena Fagundes Camelier, Fernanda Warken Rosa |
dc.subject.por.fl_str_mv |
Incontinência Urinária Tratamento Farmacológico Doença pulmonar obstrutiva crônica. Incontinencia Urinaria Tratamiento Farmacológico Enfermedad pulmonar obstructiva crónica. Urinary Incontinence Pharmacological treatment Chronic obstructive pulmonary disease. |
topic |
Incontinência Urinária Tratamento Farmacológico Doença pulmonar obstrutiva crônica. Incontinencia Urinaria Tratamiento Farmacológico Enfermedad pulmonar obstructiva crónica. Urinary Incontinence Pharmacological treatment Chronic obstructive pulmonary disease. |
description |
Chronic Obstructive Pulmonary Disease (COPD) is a lung disease, often associated with smoking. COPD patients have persistent, including urinary incontinence. Therefore, a research has the general objective of knowing the physiological mechanism of urinary incontinence associated with the pharmacological treatment of COPD. As a methodological process, this study is an integrative review that included randomized clinical trials, quasi-experimental intervention studies, cohort and case-control. The selection of studies was carried out in the databases PubMed, SciELO, Science Direct and BVS (Virtual Health Library), published between 2010 and July 2020, in Portuguese and English. Pharmacological classes SABA, LABA, SAMA, LAMA, ICS and iPDE4 were considered to investigate adverse effects and check for the presence of urinary symptoms caused by these drugs. In the results and discussion, 113 articles were identified with the investigated descriptors. After the article selection process, 14 studies resulted: PubMED (13); and Science Direct (1). The pharmacological class related to urinary incontinence identified in this study was that of anticholinergics / antimuscarinics. From this perspective, it can be considered that Urinary Incontinence has a low relationship with the adverse effects of drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD). However, as urinary incontinence is not considered a life-threatening problem, it is possible that it has not been included among the adverse events to be explored. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-07-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17558 10.33448/rsd-v10i9.17558 |
url |
https://rsdjournal.org/index.php/rsd/article/view/17558 |
identifier_str_mv |
10.33448/rsd-v10i9.17558 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/17558/15873 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 9; e3810917558 Research, Society and Development; Vol. 10 Núm. 9; e3810917558 Research, Society and Development; v. 10 n. 9; e3810917558 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052682580525056 |